resveratrol has been researched along with Vascular Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Breen, DM; Dalvi, PS; Dolinsky, VW; Giacca, A; Gonzalez Medina, M; Guo, J; Heximer, SP; McBurney, MW; McCole, DF; Mori, Y; Pereira, TJ; Tsiani, EL; Zhang, H | 1 |
| Albertini, M; Calvillo, L; Casana, R; Cilurzo, F; Mazzola, S; Selmin, F; Tolva, V; Zerbi, P | 1 |
| Bendeck, MP; Breen, DM; Dandona, P; Dolinsky, VW; Dyck, JR; Ghanim, H; Giacca, A; Guo, J; Heximer, SP; Mroziewicz, M; Tsiani, EL; Zhang, H | 1 |
3 other study(ies) available for resveratrol and Vascular Injuries
| Article | Year |
|---|---|
Resveratrol Inhibits Neointimal Growth after Arterial Injury in High-Fat-Fed Rodents: The Roles of SIRT1 and AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Carotid Artery Injuries; Carotid Artery, Common; Diet, High-Fat; Disease Models, Animal; Femoral Artery; Insulin Resistance; Mice, Knockout; Neointima; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Sirtuin 1; Vascular System Injuries | 2020 |
A successful experimental model for intimal hyperplasia prevention using a resveratrol-delivering balloon.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Coated Materials, Biocompatible; Disease Models, Animal; Equipment Design; Humans; Hyperplasia; Iliac Artery; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Rabbits; Resveratrol; Stilbenes; Vascular Access Devices; Vascular System Injuries | 2016 |
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.
Topics: Administration, Oral; Animals; Aorta; Cardiovascular Agents; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Femoral Artery; Gene Expression Regulation; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Neointima; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Time Factors; Vascular System Injuries | 2012 |